Alimentiv Inc.
17
5
9
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
17.6%
3 terminated/withdrawn out of 17 trials
40.0%
-46.5% vs industry average
35%
6 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
Role: lead
Determination of the Optimal Treatment Target in Ulcerative Colitis
Role: lead
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Role: lead
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Role: lead
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Role: lead
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Role: lead
A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants
Role: collaborator
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Role: collaborator
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
Role: lead
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
Role: lead
EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease
Role: collaborator
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
Role: collaborator
Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection
Role: collaborator
Assessment of Patients With Acute Pouchitis Treated With Antibiotics
Role: lead
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
Role: lead
Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy
Role: lead
Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
Role: lead
All 17 trials loaded